DK113388D0 - Laegemiddel med forsinket afgivelse af virksomt stof - Google Patents

Laegemiddel med forsinket afgivelse af virksomt stof

Info

Publication number
DK113388D0
DK113388D0 DK113388A DK113388A DK113388D0 DK 113388 D0 DK113388 D0 DK 113388D0 DK 113388 A DK113388 A DK 113388A DK 113388 A DK113388 A DK 113388A DK 113388 D0 DK113388 D0 DK 113388D0
Authority
DK
Denmark
Prior art keywords
medicine
active substance
active ingredient
delayed delivery
pellets
Prior art date
Application number
DK113388A
Other languages
English (en)
Other versions
DK113388A (da
Inventor
Christian Fechner
Michael Huempel
Fred Windt-Hanke
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6304389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK113388(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK113388A publication Critical patent/DK113388A/da
Publication of DK113388D0 publication Critical patent/DK113388D0/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
DK113388A 1986-07-02 1988-03-02 Laegemiddel med forsinket afgivelse af virksomt stof DK113388D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863622487 DE3622487A1 (de) 1986-07-02 1986-07-02 Arzneimittel mit verzoegerter wirkstoffabgabe
PCT/DE1987/000295 WO1988000046A1 (fr) 1986-07-02 1987-06-29 Medicaments a liberation retardee du principe actif

Publications (2)

Publication Number Publication Date
DK113388A DK113388A (da) 1988-03-02
DK113388D0 true DK113388D0 (da) 1988-03-02

Family

ID=6304389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK113388A DK113388D0 (da) 1986-07-02 1988-03-02 Laegemiddel med forsinket afgivelse af virksomt stof

Country Status (9)

Country Link
EP (1) EP0274498B2 (da)
JP (1) JP2569100B2 (da)
AT (1) ATE67087T1 (da)
AU (2) AU7643187A (da)
DE (2) DE3622487A1 (da)
DK (1) DK113388D0 (da)
FI (1) FI880839L (da)
NO (1) NO880760D0 (da)
WO (1) WO1988000046A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9205296A (pt) * 1991-05-24 1993-07-27 British Broadcasting Corp Metodo para compensacao de movimento de sinal de video,aparelho para compensacao de movimento de video e metodo e aparelho para derivar um conjunto de vetores de movimento
DE19808634A1 (de) 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
DE10318897B4 (de) * 2003-04-22 2007-04-26 Levin, Felix, Dr. Stabilisierte universell einsetzbare Testformulierung und Testkit zur Eiweißbestimmung in biologischen Flüssigkeiten
FR2894143B1 (fr) * 2005-12-01 2008-05-02 Pierre Fabre Medicament Sa Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
EP0187799A1 (en) * 1984-06-27 1986-07-23 Instrumentation Systems Limited Liquid powered cleaning apparatus

Also Published As

Publication number Publication date
EP0274498B2 (de) 1994-08-17
FI880839A0 (fi) 1988-02-23
DE3622487A1 (de) 1988-01-14
AU7643187A (en) 1988-01-29
ATE67087T1 (de) 1991-09-15
AU7817891A (en) 1991-09-05
NO880760L (no) 1988-02-22
JP2569100B2 (ja) 1997-01-08
WO1988000046A1 (fr) 1988-01-14
FI880839A7 (fi) 1988-02-23
FI880839L (fi) 1988-02-23
DK113388A (da) 1988-03-02
EP0274498B1 (de) 1991-09-11
JPH01500992A (ja) 1989-04-06
EP0274498A1 (de) 1988-07-20
DE3772954D1 (de) 1991-10-17
NO880760D0 (no) 1988-02-22

Similar Documents

Publication Publication Date Title
GR910100283A (el) Στερεά από του στόματος χορηγουμένη φαρμακευτική μορφή δοσιμετρήσεως προγραμματισμένου ρυ?μού απελευ?ερώσεως.
DE69229949D1 (de) Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe
ES2051698T3 (es) Granulos destinados a permanecer en el estomago.
ATE91232T1 (de) Hydroxypropylcelluloseether enthaltende mittel mit verzoegerter wirkstoffabgabe.
ATE66143T1 (de) Feste zubereitung mit langsamer freisetzung.
DE68913979D1 (de) Kationenaustauscherharze und carboxylgruppenhaltige Kunstharze enthaltende Arzneizubereitungen mit verzögerter Wirkstofffreisetzung.
NO871774L (no) Medikament-system med kontrollert frisettelse av det aktive middel.
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69106501D1 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
DK288987D0 (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
NO20064159L (no) Nye, biologisk aktive polypeptider, deres fremstilling og farmasoytiske preparater inneholdende polypeptidene
DK344586A (da) Tidskontrolleret laegemiddelafgivelse
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
FR2542998B1 (fr) Nouvelle forme transdermale du dinitrate d'isosorbide
DK98088A (da) Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
DK0615442T3 (da) Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse.
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
FI891865A7 (fi) Atselastiinia sisältäviä lääkkeitä, joista vaikuttava aine vapautuu säädellysti
DE3070546D1 (de) Hydroxyalkyl starch drug carrier
DK6181A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater i tabletform med langvarig afgivelse af det virksomme stof
DK113388A (da) Laegemiddel med forsinket afgivelse af virksomt stof
DK0540813T3 (da) Acetazolamid-præparat med vedvarende afgift af aktivt stof
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment